FDA Approvals, News & Updates

FDA News - October 2016

FDA Approvals, News & Updates, In the News

October 2016, Vol 7, No 9

Tecentriq (Atezolizumab) First PD-L1 Inhibitor Approved for Patients with Advanced or Metastatic Urothelial Carcinoma

By Lisa A. Raedler, PhD, RPh

Drug Updates, FDA Approvals, News & Updates

September 2016, Vol 7, No 8

FDA News - July 2016

FDA Approvals, News & Updates

July 2016, Vol 7, No 6

FDA News - June 2016

FDA Approvals, News & Updates

June 2016, Vol 7, No 5

FDA News - May 2016

FDA Approvals, News & Updates

May 2016, Vol 7, No 4

FDA News - April 2016

FDA Approvals, News & Updates

April 2016, Vol 7, No 3

FDA News - March 2016

FDA Approvals, News & Updates, In the News

March 2016, Vol 7, No 2

FDA News - December 2015

FDA Approvals, News & Updates

December 2015, Vol 6, No 11

FDA News - November 2015

FDA Approvals, News & Updates

November 2015, Vol 6, No 10

FDA News - October 2015

FDA Approvals, News & Updates, In the News

October 2015, Vol 6, No 9

Page 28 of 37

25
26
27
28
29
30
31